Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients

被引：0
|
作者：
J Solé Violan
J Ferrer Agüero
B Sádaba
S Sancho
R Zaragoza
P Luque
M Nieto
M López
F García
C Hernández
J Azanza
机构：
[1] HUGC Dr Negrín,
[2] Universidad de Navarra,undefined
[3] Hospital Dr Peset,undefined
[4] Hospital Clínico,undefined
[5] Hospital General Yagüe,undefined
[6] Hospital Morales Meseguer,undefined
来源：
Critical Care | / 18卷 / Suppl 1期
关键词：
Renal Failure; Emergency Medicine; Multicenter Study; Pharmacokinetic Parameter; Acute Renal Failure;
D O I：
10.1186/cc13593
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Pharmacokinetics of meropenem during intermittent and continuous intravenous application in patients treated by continuous renal replacement therapy
    Langgartner, Julia
    Vasold, Antje
    Glueck, Thomas
    Reng, Michel
    Kees, Frieder
    [J]. INTENSIVE CARE MEDICINE, 2008, 34 (06) : 1091 - 1096
  • [32] Population pharmacokinetics and simulations of imipenem in critically ill patients undergoing continuous renal replacement therapy
    Li, Sanwang
    Xie, Feifan
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 53 (01) : 98 - 105
  • [33] Cefepime Population Pharmacokinetics and Target Attainment in Critically Ill Patients on Continuous Renal Replacement Therapy
    Al-Shaer, Mohammad H.
    Philpott, Carolyn D.
    Droege, Christopher A.
    Courter, Joshua D.
    Healy, Daniel P.
    Droege, Molly E.
    Ernst, Neil E.
    Mueller, Eric W.
    Peloquin, Charles A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (06)
  • [34] Applying Cefepime Population Pharmacokinetics to Critically Ill Patients Receiving Continuous Renal Replacement Therapy
    Al-Shaer, Mohammad H.
    Maguigan, Kelly
    Ashton, Jennifer
    Venugopalan, Veena
    Droege, Molly E.
    Philpott, Carolyn D.
    Droege, Christopher A.
    Healy, Daniel P.
    Mueller, Eric W.
    Peloquin, Charles A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (01)
  • [35] A primer on continuous renal replacement therapy for critically ill patients
    Joy, MS
    Matzke, GR
    Armstrong, DK
    Marx, MA
    Zarowitz, BJ
    [J]. ANNALS OF PHARMACOTHERAPY, 1998, 32 (03) : 362 - 375
  • [36] Continuous renal replacement therapy in critically ill pediatric patients
    Zobel, G
    Ring, E
    Rodl, S
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (05) : S28 - S34
  • [37] Anticoagulation for continuous renal replacement therapy in critically ill patients
    Fernandez-Lorente, L.
    [J]. ANALES DEL SISTEMA SANITARIO DE NAVARRA, 2018, 41 (01) : 131 - 133
  • [38] CEFEPIME PHARMACOKINETICS IN CRITICALLY ILL CHILDREN UNDERGOING CONTINUOUS RENAL REPLACEMENT THERAPY
    Pavia, K.
    Hambrick, H.
    Paice, K.
    Tang, P.
    Vinks, A.
    Kaplan, J.
    Mizuno, T.
    Girdwood, S. Tang
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S40 - S40
  • [39] Levetiracetam pharmacokinetics in critically ill patients undergoing renal replacement therapy
    Chappell, Kathryn
    Kimmons, Lauren A.
    Haller, J. Tyler
    Canada, Robert B.
    He, Hui
    Hudson, Joanna Q.
    [J]. JOURNAL OF CRITICAL CARE, 2021, 61 : 216 - 220
  • [40] AMINOGLYCOSIDE PHARMACOKINETICS IN CRITICALLY ILL PATIENTS UNDERGOING RENAL REPLACEMENT THERAPY
    Krueger, Chelsea
    Tverdek, Frank
    Hernandez, Mike
    Abudayyeh, Ala
    Bruno, Jeffrey
    [J]. CRITICAL CARE MEDICINE, 2019, 47
12345